Grb2-SH3 ligand inhibits the growth of HER2+ cancer cells and has antitumor effects in human cancer xenografts alone and in combination with docetaxel. - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue International Journal of Cancer Année : 2007

Grb2-SH3 ligand inhibits the growth of HER2+ cancer cells and has antitumor effects in human cancer xenografts alone and in combination with docetaxel.

Résumé

HER2 represents an important signaling pathway in breast and other cancers. Herceptin has demonstrated clinical activity, but resistance is common. Thus, new therapeutic approaches to the HER2 pathway are needed. Grb2 is an adaptor protein involved in Ras-dependent signaling induced by HER2 receptors. A specific Grb2-SH3 ligand, designed and synthesized in our laboratory, called peptidimer-c, inhibited colony formation in HER2 overexpressing SKBr3 cancer cells. Combined treatment of peptidimer-c with docetaxel further inhibited both colony formation and tumor cell survival compared to docetaxel treatment alone. Efficacy of this combined treatment was correlated with a reduction in the phosphorylation of MAPK and AKT. Finally, peptidimer-c reduced the growth of a HER2(+) human breast cancer (BK111) xenograft in nude mice and potentiated the antitumor effect of docetaxel in a HER2+ hormone-independent human prostate adenocarcinoma (PAC120 HID28) xenograft. These results validate Grb2 as a new target for the HER2 pathway.
Fichier principal
Vignette du fichier
inserm-00168667_edited.pdf (1.02 Mo) Télécharger le fichier
figures_gril_et_al_new_version.ppt (5.92 Mo) Télécharger le fichier
gril_et_al_revised.pdf (262.17 Ko) Télécharger le fichier
Format : Autre
Loading...

Dates et versions

inserm-00168667 , version 1 (04-09-2009)

Identifiants

Citer

Brunilde Gril, Michel Vidal, Franck Assayag, Marie-France Poupon, Wang-Qing Liu, et al.. Grb2-SH3 ligand inhibits the growth of HER2+ cancer cells and has antitumor effects in human cancer xenografts alone and in combination with docetaxel.. International Journal of Cancer, 2007, 121 (2), pp.407-15. ⟨10.1002/ijc.22674⟩. ⟨inserm-00168667⟩
336 Consultations
748 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More